NFS1 is found overexpressed in patients with lung adenocarcinoma, and increased levels of NFS1 promote growth of primary lung tumor cells in vitro, whereas NFS1 knockdown improves anticancer activity of ferroptosis-inducing compounds in lung cancer cells (Alvarez et al., 2017). This evidence concerns the gene NFS1 and lung carcinoma.